2011 - CTS-IXA


This page contains exclusive content for the member of the following sections: TTS, CTS, IXA. Log in to view.

Cell Transplant Poster Viewing (Cell Track)

58.5 - Bone marrow-derived stem cells in human liver diseases

Presenter: Mª Trinidad, Serrano, ZARAGOZA, Spain
Authors: Estela Solanas1, F. Javier Arangurena2, Javier Godino1, Jose Antonio Moreno3, M. Angel De Gregorio4, Joaquin Medrano4, Jose Carlos Segovia5, Sara Lorente2, Trinidad Serrano2

P005

Bone marrow-derived stem cells in human liver diseases

Estela Solanas1, F. Javier Arangurena2, Javier Godino1, Jose Antonio Moreno3, M. Angel De Gregorio4, Joaquin Medrano4, Jose Carlos Segovia5, Sara Lorente2, Trinidad Serrano2

1Instituto Aragones de Ciencias de la Salud, IIS Aragon, Zaragoza; 2Hepatology and Liver Transplantation, Hospital Clinico Lozano Blesa, Zaragoza; 3Hematology, Hospital Clinico Lozano Blesa, Zaragoza; 4Interventional Radiology, Hospital Clinico Lozano Blesa, Zaragoza; 5Hematopoiesis and Gene Therapy, CIEMAT, Madrid, Spain

Bone marrow (BM) seems to play an important role in regeneration after liver injury. Several growth factors and cytokines such as HGF, SDF-1 and VEGF, released during injury act as powerful chemoattractantsto BM progenitor cells. One of the primary signals that the stemcells receive after tissue injury may be the hypoxia-inducedlocal activation of HGF that could act, in a gradient-dependent manner, to induce stem cell migration into thedamaged tissue. Although there are data supporting this hypothesis in animal studies, there is little information about these phenomena in humans.

Objective: To study the role and mechanisms of BM progenitor cells in liver injury in humans.

Patients and methods: Peripheral blood was recollected from 16 patients with acute hepatitis (AH), 7 with liver cirrhosis (LC), 7 with acute on chronic liver disease (AOC) and 7 healthy controls (HC). BM stem cells were analyzed by flow cytometry measuring CD34+, CD131+, CXCR4+, VEGF-2R+, c-KIT+, populations. Growth factors and cytokines (VEGF, HGF, SDF-1, G-CSF, SCF, MPP9, IL-3, IL-6 and IL-8) were quantified by luminex technology in peripheral and suprahepatic blood.

Results: Significant BM mobilization was detected in patients with HA. In this group CD34+ cells were 0.052%±0.03 versus 0.020%±0.01 in LC patients, and VEGFR-2+ cells were 0.078%±0.08 versus 0.017± 0.09. AH group had also higher levels of VEGF (933.4±824.7 pg/ml versus 464±730 pg/ml) and HGF (6700.9±4561 pg/ml versus 1930.6±886 pg/ml) than LC patients. All these differences were significant (p<0,05). HGF levels were three times higher in suprahepatic (24879±31119 pg/ml) than in peripheral blood (8038±8613 pg/ml).

Conclusion: Growth factors released in acute liver injury could induce bone marrow mobilization indicatingthat bone marrow stem cell could play an important role in liver regeneration in humans.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada